학술논문

Current diagnostic strategies for undifferentiated tumours of the nasal cavities and paranasal sinuses.
Document Type
Article
Source
Histopathology. Dec2011, Vol. 59 Issue 6, p1034-1045. 12p. 8 Color Photographs, 2 Charts.
Subject
*PARANASAL sinus cancer
*MORPHOLOGY
*PATHOLOGISTS
*BIOPSY
*IMMUNOHISTOCHEMISTRY
*MOLECULAR biology
*ELECTRON microscopy
Language
ISSN
0309-0167
Abstract
Franchi A, Palomba A & Cardesa A (2011) Histopathology 59, 1034-1045 Current diagnostic strategies for undifferentiated tumours of the nasal cavities and paranasal sinuses Several malignant tumours occurring in the sinonasal tract may present with an undifferentiated morphology. Overall, these lesions pose significant diagnostic difficulties for the surgical pathologist, especially in limited biopsy material, but their correct classification is becoming increasingly important for an appropriate treatment strategy. This review deals with the criteria for differential diagnosis of these neoplasms, with emphasis on recent advances in immunohistochemistry and molecular biology, as well as with previous progress in electron microscopy. Through careful microscopic examination of haematoxylin and eosin-stained sections, in the light of clinical information and imaging data, a list of differential diagnoses can be made and an appropriate panel of antibodies can be chosen to further categorize the tumour. An initial panel including cytokeratins, synaptophysin, S100 protein, desmin and CD45 may allow the classification of most lesions or may help to narrow the list of differential diagnoses. Further refinement can be obtained through second-line markers, including in-situ hybridization for Epstein-Barr virus, other neuroendocrine markers, melanocytic markers, myogenin, CD99, other lymphocyte markers, and CD138 and light chains. Finally, molecular analysis can further assist in the recognition of specific entities such as nuclear protein in testis midline carcinoma, Ewing's sarcoma/peripheral neuroectodermal tumour, alveolar rhadbomyosarcoma, and poorly differentiated synovial sarcoma. [ABSTRACT FROM AUTHOR]